Absence of detectable HIV-1 viremia after treatment cessation in an infant.
about
Non-instrumented incubation of a recombinase polymerase amplification assay for the rapid and sensitive detection of proviral HIV-1 DNAAnimal Models for HIV Cure ResearchInteraction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System DiseaseDesigning and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1Role of Marine Natural Products in the Genesis of Antiviral AgentsEnhancing Human Immunodeficiency Virus-Specific CD8(+) T Cell Responses with Heteroclitic PeptidesHow does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?Preventing HIV infection: pre-exposure and postexposure prophylaxisVery early combination antiretroviral therapy in infants: prospects for cureAnimal models in HIV cure researchHIV-1 functional cure: will the dream come true?Towards an HIV cure based on targeted killing of infected cells: different approaches against acute versus chronic infectionImpact of antiretroviral therapy (ART) timing on chronic immune activation/inflammation and end-organ damageEmerging strategies to deplete the HIV reservoirT memory stem cells and HIV: a long-term relationshipMulti-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque ControllersCell-to-cell contact facilitates HIV transmission from lymphocytes to astrocytes via CXCR4.Ending the HIV/AIDS epidemic in low- and middle-income countries by 2030: is it possible?Using animal models to overcome temporal, spatial and combinatorial challenges in HIV persistence researchOngoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory AgentsHost factors and early treatments to restrict paediatric HIV infection and early disease progressionActive targeted drug delivery for microbes using nano-carriersImmune activation and paediatric HIV-1 disease outcomeEffects of Zidovudine Treatment on Heart mRNA Expression and Mitochondrial DNA Copy Number Associated with Alterations in Deoxynucleoside Triphosphate Composition in a Neonatal Rat ModelSynergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb ActivationSerious adverse events are uncommon with combination neonatal antiretroviral prophylaxis: a retrospective case reviewReal-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIVPredicting the outcomes of treatment to eradicate the latent reservoir for HIV-1Advances in biosensing strategies for HIV-1 detection, diagnosis, and therapeutic monitoring.Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?Dual Electrophoresis Detection System for Rapid and Sensitive Immunoassays with Nanoparticle Signal Amplification.Developments in HIV-1 immunotherapy and therapeutic vaccination.The last and first frontier--emerging challenges for HIV treatment and prevention in the first week of life with emphasis on premature and low birth weight infants.Getting to 90-90-90 in paediatric HIV: What is needed?Antiretroviral treatment in HIV-infected infants and young children: novel issues raised by the Mississippi babyInduction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.Global HIV epidemiology: A guide for strategies in prevention and care.Immunologic strategies for HIV-1 remission and eradication.Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys.Immunity to HIV in Early Life
P2860
Q21089662-77E752BA-59A6-4598-A181-CA845A3176FEQ26767476-478E9121-4C7B-4062-B383-0E725D170429Q26770397-E76DD90F-E4B3-4F78-9D54-88DBD5F694A5Q26781918-B7156D3E-DEBF-4913-9F64-A0B47645D34CQ26796360-0AF97E0C-F95D-41B9-A47C-52FF4D278457Q26800123-156804D1-D976-482B-8354-2F3513EE72C4Q26822422-12DD5989-7502-4066-9C6F-F9EDBFC18879Q26828445-4CC93D43-1F45-4B40-BCE1-206B6EFDCAE4Q26830063-77B7079A-91A5-4CFE-B4C5-1F33AA77EFE2Q26853069-98D0D90F-AAA1-4572-B0F0-3D4BFFC9F2D8Q26865803-10320049-EC93-4DA6-8BF4-4BC195CBE57BQ27005830-F94BEA87-D3A5-475B-B4C9-4A3C79732CACQ27014077-60F2CF52-E752-4447-B1C9-A12035F02DE3Q27023877-682413DF-EB2A-4B63-A900-A275029559DAQ27023930-A82DF49F-86A8-4A0F-84CF-585B0C4A75BFQ27312050-6F9AF1F8-5048-4138-9512-F922F59D71A3Q27313520-CF901C26-74EF-480D-96A4-36AD6BBA1CAEQ28073723-266D200B-759F-4F54-A967-7E37DD982FA8Q28077662-0069C970-4D09-49C1-AE41-1F3E9530BDA0Q28079455-A207A0B5-96CB-4B41-B94E-F97815FE2315Q28082411-C0711982-3FC3-4DA2-9801-1E4FC292C5AAQ28082463-C744E2D3-0CEE-42AE-9A8E-542B0FFFEF1DQ28086888-7139A4E0-39C7-40B1-865A-3AE89C31D477Q28389095-4B1CDF67-8BE5-44DF-95ED-FBB5A9819C52Q28546901-7D5E5E63-76DE-4211-9FEC-5944641AA618Q28547429-72579DBC-B110-4398-BB98-B271B1704157Q28551642-AA27F3F3-2460-4BB3-A2B6-30DBC53FB070Q28655602-72B75E3C-AFDC-4F57-A756-781381C9267AQ30249830-731C29C2-35CC-461D-BDD8-BA960BB6218EQ30362489-A646C606-0A45-457A-A0DA-3CA16C64ED35Q30362912-40F4ECDD-835F-4B53-BA78-A0B826E7475DQ30364312-BAD2D7D9-0536-49B7-A003-0BEB9CDC0F81Q30382184-C30F8279-9840-46E0-B993-90A5C5E5E2FFQ30385352-FF3085C5-D872-4C66-A9E2-C861712709B4Q33557037-0885AB65-1ED9-402D-B70A-998A0CC2C8DEQ33611645-BF82D382-44AB-4A0A-8E8A-C26DCFAE6E77Q33703135-220CBEA2-2AE9-4FC4-AF62-9367CC80D899Q33896523-4EECE66B-50C3-43AC-AF50-0502C138E789Q34020988-BBEA8D4E-5DD1-42C3-A5AA-2CFB0257A232Q34033051-CD14DF4A-C5B4-419D-A9D8-31E7EEC61BAB
P2860
Absence of detectable HIV-1 viremia after treatment cessation in an infant.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Absence of detectable HIV-1 viremia after treatment cessation in an infant.
@ast
Absence of detectable HIV-1 viremia after treatment cessation in an infant.
@en
Absence of detectable HIV-1 viremia after treatment cessation in an infant.
@nl
type
label
Absence of detectable HIV-1 viremia after treatment cessation in an infant.
@ast
Absence of detectable HIV-1 viremia after treatment cessation in an infant.
@en
Absence of detectable HIV-1 viremia after treatment cessation in an infant.
@nl
prefLabel
Absence of detectable HIV-1 viremia after treatment cessation in an infant.
@ast
Absence of detectable HIV-1 viremia after treatment cessation in an infant.
@en
Absence of detectable HIV-1 viremia after treatment cessation in an infant.
@nl
P2093
P2860
P356
P1476
Absence of detectable HIV-1 viremia after treatment cessation in an infant.
@en
P2093
Carrie Ziemniak
Deborah Persaud
Douglas Richman
Hannah Gay
Katherine Luzuriaga
Matthew Strain
Michael Piatak
Ya Hui Chen
P2860
P304
P356
10.1056/NEJMOA1302976
P407
P577
2013-10-23T00:00:00Z